Squill opiate linctus paediatric
Lowest controls; includes some codeine preparations
Legal requirements and restrictions
Preparations containing controlled drugs in low concentrations. Subject to minimal controls - mainly invoicing requirements.
Legal requirements
- No special prescription requirements
- No controlled drugs register required
- No safe custody requirements
- Invoices must be retained for 2 years
Other medicines in this category
Codeine linctus, Co-codamol (low strength), Kaolin and morphine
Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Official medicine documents
Yellow Card
Report side effects (MHRA)
Drug safety updates
MHRA alerts for Camphorated opium + Squill oxymel
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Browse all Drug Analysis Profiles A–Z
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
Search EudraVigilance database
Browse substances A–Z in the European adverse reaction database
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
1 branded products available
Therapeutically similar medicines
Similarity is based on WHO Anatomical Therapeutic Chemical (ATC) classification and on a factual NHS dm+d therapeutic-grouping code prefix. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.
NHS prescribing volume and spending trends
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0.
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing the 50 most relevant studies.
Randomised trials: 3 · 1910–2026
Showing the 50 most relevant studies, sorted by most relevant.
Mojtaba Taheri, Seyed Mohammad Riahi, Mohammad Kazem Emami Meybodi, et al.
Traditional and Integrative Medicine, 2023
Fatemeh Nejatbakhsh, Hossein Karegar-Borzi, Gholamreza Amin, et al.
Journal of Ethnopharmacology, 2017
Anders Byström, Rolf Claesson, Göran Sundqvist
Dental Traumatology, 1985
Maryam Mohammadi–Araghi, Alireza Eslaminejad, Hossein Karegar-Borzi, et al.
Evidence-Based Complementary and Alternative Medicine, 2022
Background. In traditional Persian medicine, Drimia maritima, with the popular name Squill, has been used to alleviate phlegm dyspnea. Squill has also been shown to have anti-inflammatory and anticholinergic properties. The goal of this research was to see how effective and safe Squill-Oxymel was in treating COPD patients. Method. Forty-two COPD patients were examined for eight weeks in two groups. Patients underwent a 6-minute walk test to assess the treatment’s effectiveness at the beginning and conclusion of the intervention. We utilized St. George’s Respiratory Questionnaire (SGRQ) to evaluate the subjective symptoms of patients in order to measure their quality of life. Results. Patients who received Squill-Oxymel showed a statistically significant increase in 6MWT distance ( P = 0.011 ). The mean O2 saturation at the end of the 6MWT before the intervention was significantly greater in the placebo group. ( P = 0.008 ). In terms of questionnaire variables, there was a significant difference between placebo and Squill-Oxymel groups in the mean presymptom score ( P = 0.009 ) and the mean post-symptom score ( P = 0.004 ). Conclusions. The findings of this research provide preliminary evidence for the effectiveness and safety of Squill-Oxymel as an add-on therapy in individuals with mild COPD.
Abstract licence: CC BY 4.0
Oxford English Dictionary, 2023
Oxford English Dictionary, 2026
Dictionary of Toxicology, 2024
hoda zain
2024
Abstract Enterococcus faecalis (E. faecalis) are the most common bacterial species in resistant or recurrent infections due to its penetration in deep dentinal layers which is difficult to clean leading to endodontic treatment failures . It comprises 6% of total flora in root canals and is seen in 22- 77% of root canal retreatment cases owing to the virulence factors it possesses. Thus, intracanal medication between appointments is recommended to further reduce bacteria in the root canal system.The aim of the present study is to evaluate the antibacterial efficacy and biocompatibility of Ca(OH)2, CPCP and a combination of Ca(OH)2 and CPCP as root canal dressing against E. faecalis in single rooted mandibular premolars compared to teeth with empty canals.
Abstract licence: CC BY 4.0
Afghanistan Opium Survey 2025, 2025
Poppies, Pipes, and People, 2024
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Scientific data (pharmacology, interactions, ADME) is not yet available for this medicine. Clinical sections are sourced from the NHS dm+d database.